The proxy contest continues with management actively soliciting votes. The outcome likely favors the board given the dissident's small ownership (~0.7%) and lack of experience. No immediate trading catalyst; monitor the annual meeting date for vote results.
Price Chart
Executive Summary
Vaxart filed definitive additional proxy materials (DEFA14A) urging shareholders to vote FOR all six board nominees and WITHHOLD on the three dissident nominees from stockholder Daniel P. Houle. The filing contains social media posts reiterating management's argument that the dissidents lack relevant clinical-stage biotech experience. This is a routine solicitation update in the ongoing proxy contest with no new material information.
Key Facts
- Vaxart filed DEFA14A urging shareholders to vote FOR all 6 board nominees and WITHHOLD on dissident nominees.
- Dissident slate from stockholder Daniel P. Houle (3 nominees) is opposed by management.
- Management argues dissidents lack relevant clinical-stage biotech experience and are undermining resolution efforts.
- Filing includes social media posts (LinkedIn, X) directing shareholders to vote.vaxart.com.
Financial Impact
No financial figures disclosed; proxy contest costs are not quantified.
Risk Factors
- Dissident could gain seats if shareholder dissatisfaction is higher than expected.
- Proxy contest may distract management from pipeline progress.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001213900-26-072727 |
| Document: 0001213900-26-072727-index-headers.html | 0001213900-26-072727 |
| Document: 0001213900-26-072727-index.html | 0001213900-26-072727 |
| Document: 0001213900-26-072727.txt | 0001213900-26-072727 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 28, 2026 9w ago | 8-K | $0.4800 $0.5000 | ▲ +4.17% | ▲ +0.79% | $0.4400 (−8.33%) |
Jul 7, 2026 12w ago | 8-K | $0.5500 $0.6000 | ▲ +9.09% | ▲ +5.93% | $0.4400 (−20.00%) |
Jul 6, 2026 12w ago | DEFA14A | $0.6200 $0.5900 | ▼ −4.84% | ▼ −5.69% | $0.4400 (−29.03%) |
Jul 2, 2026 13w ago | DEFA14A | $0.6400 $0.5490 | ▼ −14.22% | ▼ −14.52% | $0.4400 (−31.25%) |
Jul 2, 2026 13w ago | 8-K | $0.6400 $0.5200 | ▼ −18.75% | ▼ −18.34% | $0.4400 (−31.25%) |
Jun 26, 2026 13w ago | DEFA14A | $0.5700 $0.4501 | ▼ −21.04% | ▼ −20.78% | $0.4400 (−22.81%) |
Jun 26, 2026 13w ago | DEFA14A | $0.5700 $0.4501 | ▼ −21.04% | ▼ −20.78% | $0.4400 (−22.81%) |
Jun 26, 2026 13w ago | 8-K | $0.5700 $0.4501 | ▼ −21.04% | ▼ −20.78% | $0.4400 (−22.81%) |
Jun 16, 2026 15w ago | DEFA14A | $0.5600 $0.5300 | ▼ −5.36% | ▼ −6.21% | $0.4400 (−21.43%) |
Jun 8, 2026 16w ago | DEFA14A | $0.5800 $0.5502 | ▼ −5.14% | ▼ −6.53% | $0.4400 (−24.14%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access